Primary intention of our study is to evaluate how ESP block influences postoperative pain scores after laparoscopic cholecystectomy. The secondary goal is to assess ESP block effect on opioid consum Erector spinae plane block
Conditions
Interventions
A US probe are placed longitudinally at the level of the Th7 spinal process,
than moved 3 cm laterally from the midline. The ultrasound landmarks,
Th7 transverse process,
and overlying erector spinae muscle are identified. After the making of aseptic field 100-
mm,
20G Stimuplex block needle was guided in-
plane cranial-
caudal until the tip contacted the Th7 transverse process. After using of hydro-
dissection with 4ml of isotonic saline to confirm the right needle position 20ml of 0.25% levobupivacaine plus 2mg of dexamethasone will be administered below the erector spinae muscle.,At the end o
patients from both groups received acetaminophen 1g iv and ketorolac 30mg. Patients from control group received at the end of operation as part of our hospital multimodal analgesia protocol tramadol
10) using defined postoperative time intervals (10 min,
30 min,
2h,
4h,
8h,
12h and 24h ). Pain scores were recorded by attending recovery and ward staff who were blinded to which group the patient was in
Erector spinae plane block,Control group
Sponsors
None
Eligibility
Sex/Gender
All
Age
20 Years to 65 Years
Inclusion criteria
Inclusion criteria: Every patient scheduled for elective laparoscopic cholecistectomy
Exclusion criteria
Exclusion criteria: Patient enrolment refusal, blood coagulation pathology, relevant drug allergy, pregnancy, alcohol or drug abuse, morbid obesity (BMI≥35), severe liver or kidney disease, chronic opioid use or inability to understand the study protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lower postoperative pain 30 minutes, 2h,4h,8h and 24h after the operation Numeric rating scale (1-10) for detection of pain | — |
Secondary
| Measure | Time frame |
|---|---|
| Lower postoperative tramadol consumtion 24h evaluation of pain | — |
Countries
Serbia
Contacts
Public ContactMirka Lukić-Šarkanović
Clinical center of Vojvodina
Outcome results
None listed